The Partnership for Vivax Elimination (PAVE) led by PATH and Medicines for Malaria Venture (MMV) brings together National Malaria Programs (NMPs), researchers, funders, and other organizations to support countries as they strive to achieve their elimination goals through:

▪ Working with NMPs to identify optimal radical cure tools and strategies for their given contexts.

▪ Generating and sharing high-quality evidence on Plasmodium vivax (P. vivax) case management to inform policy decisions and implementation by national governments

▪ Advancing the development and availability of quality-assured medicines and diagnostics for P. vivax.